A 58-year-old man with onset of gout 8 years ago was admitted due to poor clinical conditions. He was treated with allopurinol 300 mg/day, but the dosage was not adjusted to the level of persistent uricemia (11 mg/dl). In this scenario, our patient experienced recurrent polyarticular gouty attacks despite being adherent to the prescribed therapy. Gigantic tophi ( Fig. 1a, b ), walking difficulties and feet ulcers due to spontaneous evacuation of a tophus were clinically evident. Hands and feet X-ray showed multiple destructive bone erosions due to large tophaceous depositions ( Fig. 1c, d ). Musculoskeletal ultrasound (MSUS) identified the presence of double contour sign (DCS, arrow) in the metacarpophalangeal joint and active synovitis in the joints of hands and feet (Fig. 1e, f, *) . Monosodium urate (MSU) crystals were detected in the knee fluid as well as in the ulcerated tophaceous deposits. According to EULAR recommendations, colchicine 1 mg/day, NSAIDs, omeprazole 20 mg/day and urate lowering therapy with allopurinol adjusted to uric acid levels (600 mg/ day) were prescribed. Knee fluid aspiration and intra-articular long-acting corticosteroid injection (Betamethasone) were performed [1] . Other laboratory analyses, renal/ cardiac function and systemic blood pressure were normal. No kidney stones were detected. In the following two months, uric acid levels were significantly lowered (5.7 mg/dl). Febuxostat was identified as a potential future alternative therapy in case high dosage intolerance/side effects to allopurinol would appear. Follow-up visits in the next 18 months did not identify new joint/ periarticular attacks. The ulcers showed a trend toward resolution but did not reach complete healing. Less walking difficulties were recorded mainly due to knee joint pain reduction.
Presentation
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Discussion
Gout is a metabolic disease characterized by formation and reversible deposition of MSU crystals in joints and extraarticular tissues (the kidney, heart, central nervous system, eye), usually occurring after a prolonged period of hyperuricemia. Suspicion of gout is based on typical clinical and laboratory (i.e. hyperuricaemia) findings, while definitive diagnosis is achieved with the identification of MSU crystals in synovial fluid or tophi. [2] .
In the early stages, X-rays are less useful for diagnosis due to the non-specific soft tissue swelling overlying the inflamed joint. The radiographic features of longstanding gout include central, marginal, or periarticular erosions with sclerotic margins and overhanging edges, joint space narrowing and dense soft tissue tophi that may generate lytic articular bone lesions and subsequent fractures [2] . Instead, MSUS can be used for diagnosis and management of gout from the first attack as well as during follow-up. The MSUS findings in gout are specific (DCS of the articular hyaline cartilage, MSU aggregates and tophus) or non-specific (synovial fluid, synovial hypertrophy, Doppler signal, erosions) [2] . For some of these findings, OMERACT definitions were recently established [3] . The DCS is considered a highly specific finding [4] and is included in the ACR/EULAR gout classification criteria [5] . Indeed, a recent meta-analysis demonstrated that MSUS offers good diagnostic accuracy. Therefore, MSUS plays an important role in gout diagnosis and helps in differentiating gout from other arthritic diseases [6] .
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